Pneumocystis Pneumonia in Non-HIV Pregnant Women Receiving Chemotherapy for Malignant Lymphoma: Two Case Reports.
Yuki FukutaniYoshitsugu ChigusaEiji KondohKaoru KawasakiShingo IoNoriomi MatsumuraPublished in: Case reports in obstetrics and gynecology (2017)
Pneumocystis pneumonia (PCP) is a life-threatening opportunistic infection that sometimes occurs in immunocompromised patients with human immunodeficiency virus (HIV). Here, we report two extremely rare cases of PCP in non-HIV pregnant women who underwent chemotherapy for malignant lymphoma. Case 1 is a 34-year-old primigravida who was diagnosed with Hodgkin's lymphoma. She received ABVD chemotherapy and developed PCP at 37 weeks of gestation. After the onset of PCP, emergent cesarean section was performed due to a nonreassuring fetal status. Case 2 is a 31-year-old multigravida with diffuse large B-cell lymphoma who was administered R-CHOP chemotherapy. At 34 weeks of gestation, she complained of dyspnea and developed PCP. She delivered her baby vaginally immediately after the onset of symptoms. Both patients were treated with sulfamethoxazole-trimethoprim (ST) and recovered shortly thereafter. The babies' courses were also uneventful. PCP remains a serious cause of death, especially in non-HIV patients, and, therefore, appropriate prophylaxis and a prompt diagnosis are imperative.
Keyphrases
- human immunodeficiency virus
- diffuse large b cell lymphoma
- antiretroviral therapy
- hiv infected
- hepatitis c virus
- hiv positive
- pregnant women
- hiv aids
- hiv testing
- end stage renal disease
- newly diagnosed
- ejection fraction
- epstein barr virus
- men who have sex with men
- chronic kidney disease
- locally advanced
- gestational age
- preterm infants
- prognostic factors
- squamous cell carcinoma
- depressive symptoms
- radiation therapy
- peritoneal dialysis
- hodgkin lymphoma
- chemotherapy induced
- physical activity
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- patient reported
- microbial community